Find clinical trials for Autism. Search for oncology clinical trials in different cities and states across the United States.
Sponsor:
The University of Texas at Dallas
Location:
Code:
NCT06596226
Conditions
Autism
Eligibility Criteria
Sex: All
Age: 16 - 30
Healthy Volunteers: Not accepted
Interventions
Pathways Parent Mediated Intervention
Pathways Parent Mediated Intervention without Mutual Gaze
Sponsor:
Stanford University
Location:
Code:
NCT03778827
Conditions
Autism Spectrum Disorder
Autism
Eligibility Criteria
Sex: All
Age: 2 - 3
Healthy Volunteers: Not accepted
Interventions
Intensive Center-Based Pivotal Response Treatment (PRT-C)
Sponsor:
Elizabeth Austen Lawson
Location:
Code:
NCT05754073
Conditions
Autism Spectrum Disorder
Bone Health
Eligibility Criteria
Sex: All
Age: 6 - 18
Healthy Volunteers: Not accepted
Interventions
1. Intranasal oxytocin spray
2. Intranasal placebo spray
3. Intranasal Oxytocin spray
Sponsor:
The Center for Autism and Related Disorders
Location:
Code:
NCT00936182
Conditions
Autism Spectrum Disorder
Eligibility Criteria
Sex: All
Age: 3 - 10
Healthy Volunteers: Not accepted
Interventions
Fluconazole
Clinical trials for autism are research studies that investigate the effectiveness, safety, and potential side effects of interventions designed to improve the symptoms and quality of life for individuals with Autism Spectrum Disorder (ASD). These trials can encompass a wide range of interventions, including medications, behavioral therapies, dietary changes, and more.
Clinical trials for autism are important for several reasons, each contributing to the advancement of our understanding, treatment, and support of individuals with autism. By thoroughly researching ASD, researchers can gain biological and behavioral insights into the condition which can support the development of new therapies and optimization of existing treatments.
Medical researchers also value the investigation of autism for improving outcomes for patients, empowering them to make informed decisions based on the latest treatments available. As a result of improved treatment options for ASD, stigma can be reduced, which is hugely important for such a wide-ranging and often misunderstood condition.
Clinical trials for autism encompass a variety of study types, each designed to explore different aspects of autism and its potential treatments.
In observational studies, researchers observe participants with autism in a natural setting without intervention. These types of studies are designed to gather data to understand correlations and patterns.
Medical professionals may use a variety of methodologies in observational studies, including cohort, case-control, and cross-sectional studies. In cohort studies, researchers follow a group of individuals with autism over time to observe the natural progression of the disorder and the long-term effects of different interventions.
Case-control studies compare individuals with autism to those without the condition to identify potential causes, risk factors, or protective factors associated with ASD. In cross-sectional studies, researchers collect data at a single point in time to analyze the prevalence and characteristics of autism in a specific population.
These trials involve active intervention, where participants receive specific treatments or therapies to assess their effectiveness and safety. Interventional trials could be carried out with medication to establish the efficacy and safety of drugs designed to alleviate symptoms such as irritability, hyperactivity, anxiety, or repetitive behaviors.
Interventional trials can also use behavioral, psychological, and technological interventions for people with autism. In these studies, therapies such as social skills training, cognitive behavioral therapy (CBT), and applied behavior analysis (ABA) or apps may be used to improve social, communication, and adaptive skills.
Researchers may also use dietary or nutritional interventions to investigate the impact of special diets or nutritional supplements on autism symptoms.
In prevention trials, researchers seek to prevent the onset or reduce the severity of autism symptoms through early interventions. These trials may use interventions applied during early childhood to improve developmental outcomes. They may also explore interventions during pregnancy or shortly after birth to determine if the risk of impact of autism can be reduced.
Participating in a clinical trial for autism can be hugely beneficial, and there are several reasons why someone should get involved in one. It not only offers a unique opportunity to contribute to the advancement of scientific understanding and treatment of ASD but by joining a trial, individuals and families can play a vital role in helping researchers discover new therapies, improve diagnostic tools, and enhance support strategies.
When participating in a clinical trial for autism, participants can experience benefits such as access to new treatments that could improve their symptoms and quality of life. As part of the trial, they will also need to be closely monitored, which provides them with better and more frequent access to medical care and detailed feedback.
Participants in an autism clinical trial will be contributing to the wider medical research landscape, supporting future advancements in treatments and improved outcomes for others living with ASD. This can also be a boost to well-being and motivation throughout the trial period.
Like most clinical trials, autism clinical trials can pose risks for participants. This means there are considerations people need to think about before agreeing to take part. Participants might not experience improvement and could receive a placebo, leading to no therapeutic benefit. The time commitment required for frequent visits and strict adherence to protocols can be burdensome, and the uncertainty of outcomes may cause emotional stress.
There is also a risk of physical and psychological harm associated with certain new treatments, as well as concerns about privacy and the disruption of daily life. Despite the experimental nature of the treatments and the rigorous oversight, the benefits are not guaranteed, making it crucial for participants to be fully informed before deciding to participate in a trial.
Participation in a clinical trial for autism is typically open to individuals who meet specific eligibility criteria set by the researchers conducting the study. These criteria are designed to ensure the safety of participants and the validity of the trial results.
The eligibility requirements could include diagnosis status, age, sex, severity and type of symptoms, general health status, location, and whether they have used treatments for autism before.
Unsure about participating in clinical trials? Read through our comprehensive guide to learn about the process, benefits, and potential impact of your involvement. Get the facts you need to make an informed decision today!
Prior to the trial starting, participants in an autism clinical trial will be put through a screening process to assess eligibility. At this stage, informed consent will also be required from the participants, ensuring they fully understand the purpose of the trial, its processes and protocols, and any potential risks or benefits.
During the trial, participants may be expected to make regular visits to the study site or allow researchers into the home or other natural environment, complete assessments, adhere to treatment plans, and undergo close monitoring, particularly if taking part in a drug trial.
These requirements can be different in various trials depending on the objectives but will be outlined at the beginning of the study so expectations are managed.
Enrolling in a clinical trial studying autism through our platform is a straightforward and user-friendly process. Here's how to get started: